<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-218
Date of Submission: 2025-02-20

This report was submitted by a Nurse from Ramirez-Jackson Medical Center concerning patient ANON-PX-1725. The subject is an adult other with a significant medical history including coronary artery disease, asthma. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Intravenous route at a dosage of 386mg, initiated on 2024-12-22 for Neuropathic pain with the course ongoing.

On approximately 2025-01-15, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Nausea, Vomiting. The Anaphylaxis was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Nausea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Vomiting was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed human and advised goal. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 5 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Rule author huge it risk billion song low. Ok some whatever fast small. Upon fast government various sometimes follow would.</data>
report_id: ADR-2025-218
report_date: '2025-02-20'
patient_details:
  patient_id: ANON-PX-1725
  gender: Other
  relevant_history:
  - coronary artery disease
  - asthma
suspected_drugs:
- drug_name: Gabapentin
  dosage: 386mg
  route_of_administration: Intravenous
  start_date: '2024-12-22'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2025-01-15'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Nausea
  onset_date: '2025-01-15'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2025-01-15'
  severity: Moderate
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed human and advised goal.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 5
reporting_facility: Ramirez-Jackson Medical Center
reporter_type: Nurse
notes: Rule author huge it risk billion song low. Ok some whatever fast small. Upon
  fast government various sometimes follow would.
